Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab

This study has been completed.

Study NCT00139841 Information provided by Cephalon

First Received: August 18, 2005 Last Updated: February 4, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2009
Primary Completion Date:	July 2007 (Final data collection date for primary outcome measure)